Cite
Borst GR, Kumareswaran R, YĆ¼cel H, et al. Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 2017;8(50):87638-87646doi: 10.18632/oncotarget.20936.
Borst, G. R., Kumareswaran, R., YĆ¼cel, H., Telli, S., Do, T., McKee, T., Zafarana, G., Jonkers, J., Verheij, M., O'Connor, M. J., Rottenberg, S., & Bristow, R. G. (2017). Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget, 8(50), 87638-87646. https://doi.org/10.18632/oncotarget.20936
Borst, Gerben R, et al. "Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model." Oncotarget vol. 8,50 (2017): 87638-87646. doi: https://doi.org/10.18632/oncotarget.20936
Borst GR, Kumareswaran R, YĆ¼cel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG. Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 2017 Sep 15;8(50):87638-87646. doi: 10.18632/oncotarget.20936. eCollection 2017 Oct 20. PMID: 29152107; PMCID: PMC5675659.
Copy
Download .nbib